
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment
Yan Zou, Xinhong Sun, Yibin Wang, et al.
Advanced Materials (2020) Vol. 32, Iss. 24
Closed Access | Times Cited: 140
Yan Zou, Xinhong Sun, Yibin Wang, et al.
Advanced Materials (2020) Vol. 32, Iss. 24
Closed Access | Times Cited: 140
Showing 1-25 of 140 citing articles:
Non-viral vectors for RNA delivery
Yi Yan, Xiaoyu Liu, Lu An, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 241-279
Open Access | Times Cited: 220
Yi Yan, Xiaoyu Liu, Lu An, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 241-279
Open Access | Times Cited: 220
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, et al.
Carbohydrate Polymers (2021) Vol. 260, pp. 117809-117809
Closed Access | Times Cited: 134
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, et al.
Carbohydrate Polymers (2021) Vol. 260, pp. 117809-117809
Closed Access | Times Cited: 134
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Jia Li, Meng Zheng, Olga Shimoni, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 131
Jia Li, Meng Zheng, Olga Shimoni, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 131
Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
Yan Zou, Xinhong Sun, Qingshan Yang, et al.
Science Advances (2022) Vol. 8, Iss. 16
Open Access | Times Cited: 127
Yan Zou, Xinhong Sun, Qingshan Yang, et al.
Science Advances (2022) Vol. 8, Iss. 16
Open Access | Times Cited: 127
Glutathione-mediated nanomedicines for cancer diagnosis and therapy
Yiming Ding, Yujie Dai, Mengqi Wu, et al.
Chemical Engineering Journal (2021) Vol. 426, pp. 128880-128880
Closed Access | Times Cited: 108
Yiming Ding, Yujie Dai, Mengqi Wu, et al.
Chemical Engineering Journal (2021) Vol. 426, pp. 128880-128880
Closed Access | Times Cited: 108
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma
Huan Chen, Ting Li, Xiaogang Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 97
Huan Chen, Ting Li, Xiaogang Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 97
Tumour‐derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour‐homing and intracellular freeway transportation
Xin Zhou, Yunqiu Miao, Ying Wang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 95
Xin Zhou, Yunqiu Miao, Ying Wang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 95
Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects
Xiaojun Wang, Hui Ding, Zongyang Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 94
Xiaojun Wang, Hui Ding, Zongyang Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 94
RNA-binding proteins and cancer metastasis
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 94
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 94
Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy
Qingfei Zhang, Gaizhen Kuang, Wenzhao Li, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 89
Qingfei Zhang, Gaizhen Kuang, Wenzhao Li, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 89
An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy
Shuhan Liu, Ji Liu, Haisong Li, et al.
Biomaterials (2022) Vol. 287, pp. 121645-121645
Closed Access | Times Cited: 77
Shuhan Liu, Ji Liu, Haisong Li, et al.
Biomaterials (2022) Vol. 287, pp. 121645-121645
Closed Access | Times Cited: 77
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma
Muhammad Ismail, Wen Yang, Yanfei Li, et al.
Biomaterials (2022) Vol. 287, pp. 121608-121608
Closed Access | Times Cited: 75
Muhammad Ismail, Wen Yang, Yanfei Li, et al.
Biomaterials (2022) Vol. 287, pp. 121608-121608
Closed Access | Times Cited: 75
Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
Jun Liao, Li Fan, Yi Li, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 439-464
Closed Access | Times Cited: 58
Jun Liao, Li Fan, Yi Li, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 439-464
Closed Access | Times Cited: 58
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 44
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 44
Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing
Yu Zhao, Jie Qin, Daohan Yu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 12, pp. 1869-1879
Closed Access | Times Cited: 18
Yu Zhao, Jie Qin, Daohan Yu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 12, pp. 1869-1879
Closed Access | Times Cited: 18
Cation‐Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy
Tong Jiang, Yonghan Qiao, Weimin Ruan, et al.
Advanced Materials (2021) Vol. 33, Iss. 45
Closed Access | Times Cited: 95
Tong Jiang, Yonghan Qiao, Weimin Ruan, et al.
Advanced Materials (2021) Vol. 33, Iss. 45
Closed Access | Times Cited: 95
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 88
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 88
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions
Tianzhong Li, Jingfeng Li, Zhi Chen, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 338-370
Closed Access | Times Cited: 67
Tianzhong Li, Jingfeng Li, Zhi Chen, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 338-370
Closed Access | Times Cited: 67
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 4, pp. 355-382
Closed Access | Times Cited: 60
Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 4, pp. 355-382
Closed Access | Times Cited: 60
pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy
Xian Tang, Qinglin Sheng, Chaoqun Xu, et al.
Nano Today (2021) Vol. 37, pp. 101083-101083
Closed Access | Times Cited: 57
Xian Tang, Qinglin Sheng, Chaoqun Xu, et al.
Nano Today (2021) Vol. 37, pp. 101083-101083
Closed Access | Times Cited: 57
Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing
Qiqi Liu, Ying Zhang, Jingkai Huang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Qiqi Liu, Ying Zhang, Jingkai Huang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes
Victoria C. Vetter, Ernst Wagner
Journal of Controlled Release (2022) Vol. 346, pp. 110-135
Closed Access | Times Cited: 38
Victoria C. Vetter, Ernst Wagner
Journal of Controlled Release (2022) Vol. 346, pp. 110-135
Closed Access | Times Cited: 38